HK$
3.33
Sep 20
New Key Statistics Module, Z-Score and F-Score
HKSE:09989 Key Ratios
Market Cap HK$ M | 13,290.03 |
Enterprise Value HK$ M | 15,413.20 |
P/E(ttm) | -- |
PE Ratio without NRI | 19.76 |
Forward PE Ratio | 6.14 |
Price/Book | 1.11 |
Price/Sales | 2.41 |
Price/Free Cash Flow | 7.30 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 6,028.00 |
EPS (TTM) HK$ | -0.19 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -123.40 |
EV-to-EBIT | -98.77 |
EV-to-EBITDA | -98.77 |
PEG | -- |
Shares Outstanding M | 1,467.30 |
Net Margin (%) | -4.36 |
Operating Margin % | 14.83 |
Pre-tax Margin (%) | -5.90 |
Quick Ratio | 1.05 |
Current Ratio | 2.39 |
ROA % (ttm) | -1.25 |
ROE % (ttm) | -1.99 |
ROIC % (ttm) | 4.11 |
Dividend Yield % | -- |
Altman Z-Score | 2.12 |
HKSE:09989 Number of Guru Trades
HKSE:09989 Volume of Guru Trades
Gurus Latest Trades with HKSE:09989
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:09989 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Hepalink Pharmaceutical Group Co Ltd Insider Transactions
No Available Data